Capital Performance Advisors LLP Neogenomics Inc Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Neogenomics Inc stock. As of the latest transaction made, Capital Performance Advisors LLP holds 2 shares of NEO stock, worth $28. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2Holding current value
$28% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$123 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$94.2 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$92.7 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.76B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...